The expanded indication is for the prevention of respiratory syncytial virus-associated lower respiratory tract disease in adults aged 50 through 59 years who are at an increased risk.
Over 13 million US adults aged 50-59 years have a medical condition that increases their risk of severe RSV outcomes1 Clinical development programme continues to.
Over 13 million US adults aged 50-59 years have a medical condition that increases their risk of severe RSV outcomes1
Clinical development program continues to evaluate safety and immunogenicity.
Cayman: OfReg Board s Response to CUC s Press Release on Power Shedding ieyenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ieyenews.com Daily Mail and Mail on Sunday newspapers.